AstraZeneca PLC (ETR:ZEG)
134.25
-2.50 (-1.83%)
Mar 31, 2025, 2:43 PM CET
AstraZeneca Revenue
In the year 2024, AstraZeneca had annual revenue of $54.07B USD with 18.03% growth. AstraZeneca had revenue of $14.89B in the quarter ending December 31, 2024, with 23.84% growth.
Revenue
$54.07B
Revenue Growth
+18.03%
P/S Ratio
n/a
Revenue / Employee
$573.41K
Employees
94,300
Market Cap
211.56B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54.07B | 8.26B | 18.03% |
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
AstraZeneca News
- 2 days ago - AstraZeneca (AZN) Gains FDA Approval for New Imfinzi Indication - GuruFocus
- 2 days ago - AstraZeneca's Imfinzi gains additional indication for bladder cancer - Seeking Alpha
- 3 days ago - Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug - Benzinga
- 3 days ago - Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug - Benzinga
- 4 days ago - J&J boasts Rybrevant, Lazcluze combo bests AstraZeneca's Tagrisso - Seeking Alpha
- 5 days ago - Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca - PRNewsWire
- 5 days ago - The women behind life-saving Covid vaccine trials - BBC
- 5 days ago - AstraZeneca's TAGRISSO Shows Promising Results in Lung Cancer Trials - GuruFocus